NDC00517-5610-25: HYDROXYZINE HYDROCHLORIDE INJECT.
HYDROXYZINE HYDROCHLORIDE INJECT. Key specifications include administration: INTRAMUSCULAR, features_provided: STERILE, primary_container_type: VIAL, MULTIPLE DOSE, secondary_container_type: PACKAGE, pharmaceutical_vehicle_type: AQUEOUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-506-0484, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAMUSCULAR |
| special_features | STERILE WITH 0.9% BENZYL ALCOHOL AS PRESERVATIVE; WATER FOR INJECTION;STERILE; PH ADJUSTED WITH SODIUM HYDROXIDE AND/OR HYDROCHLORIC ACID |
| features_provided | STERILE |
| primary_container_type | VIAL, MULTIPLE DOSE |
| secondary_container_type | PACKAGE |
| pharmaceutical_vehicle_type | AQUEOUS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 25 |
| primary_container_content_quantity | 10.000 MILLILITERS |
| active_medicament_medicinal_strength | 50.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE PER MILLILITER |
| part_name_assigned_by_controlling_agency | HYDROXYZINE HYDROCHLORIDE SOLUTION FOR INJECTION USP 50MG/ML 10ML/VIAL 25EA. |
| primary_container_quantity_per_secondary_container | 25 VIAL |
| NSN | 6505-01-506-0484 |
| ADMINISTRATION | INTRAMUSCULAR |
| PRIMARY CONTAINER CONTENT QUANTITY | 10.000 MILLILITERS |
| SECONDARY CONTAINER TYPE | PACKAGE |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| FEATURES PROVIDED | STERILE |
| PRIMARY CONTAINER TYPE | VIAL, MULTIPLE DOSE |
| SPECIAL FEATURES | STERILE WITH 0.9% BENZYL ALCOHOL AS PRESERVATIVE; WATER FOR INJECTION;STERILE; PH ADJUSTED WITH SODIUM HYDROXIDE AND/OR HYDROCHLORIC ACID |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | HYDROXYZINE HYDROCHLORIDE SOLUTION FOR INJECTION USP 50MG/ML 10ML/VIAL 25EA. |
| PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER | 25 VIAL |
| PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |